Your browser doesn't support javascript.
loading
Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.
Luedeke, Manuel; Rinckleb, Antje E; FitzGerald, Liesel M; Geybels, Milan S; Schleutker, Johanna; Eeles, Rosalind A; Teixeira, Manuel R; Cannon-Albright, Lisa; Ostrander, Elaine A; Weikert, Steffen; Herkommer, Kathleen; Wahlfors, Tiina; Visakorpi, Tapio; Leinonen, Katri A; Tammela, Teuvo L J; Cooper, Colin S; Kote-Jarai, Zsofia; Edwards, Sandra; Goh, Chee L; McCarthy, Frank; Parker, Chris; Flohr, Penny; Paulo, Paula; Jerónimo, Carmen; Henrique, Rui; Krause, Hans; Wach, Sven; Lieb, Verena; Rau, Tilman T; Vogel, Walther; Kuefer, Rainer; Hofer, Matthias D; Perner, Sven; Rubin, Mark A; Agarwal, Archana M; Easton, Doug F; Al Olama, Ali Amin; Benlloch, Sara; Hoegel, Josef; Stanford, Janet L; Maier, Christiane.
Afiliação
  • Luedeke M; Institute of Human Genetics, University of Ulm, Ulm, Germany.
  • Rinckleb AE; Department of Urology, University of Ulm, Ulm, Germany.
  • FitzGerald LM; Institute of Human Genetics, University of Ulm, Ulm, Germany.
  • Geybels MS; Department of Urology, University of Ulm, Ulm, Germany.
  • Schleutker J; Fred Hutchinson Cancer Research Center, Division of Public Health Science, Seattle, Washington, USA.
  • Eeles RA; Cancer, Genetics and Immunology, Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
  • Teixeira MR; Fred Hutchinson Cancer Research Center, Division of Public Health Science, Seattle, Washington, USA.
  • Cannon-Albright L; Institute of Biomedical Technology/BioMediTech, University of Tampere, Tampere, Finland.
  • Ostrander EA; Department of Medical Biochemistry and Genetics, University of Turku, and Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, Turku, Finland.
  • Weikert S; The Institute of Cancer Research, London, UK.
  • Herkommer K; Royal Marsden National Health Service Foundation Trust, London and Sutton, UK.
  • Wahlfors T; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
  • Visakorpi T; Abel Salazar Biomedical Sciences Institute, Porto University, Porto, Portugal.
  • Leinonen KA; Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Tammela TLJ; George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, USA.
  • Cooper CS; National Human Genome Research Institute, NIH, Bethesda, MD, USA.
  • Kote-Jarai Z; Department of Urology, Vivantes Humboldt Hospital, Berlin, Germany.
  • Edwards S; Department of Urology, University Hospital Charité, Berlin, Germany.
  • Goh CL; Department of Urology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • McCarthy F; Institute of Biomedical Technology/BioMediTech, University of Tampere, Tampere, Finland.
  • Parker C; Fimlab Laboratories, Tampere University Hospital, Tampere, Finland.
  • Flohr P; Fimlab Laboratories, Tampere University Hospital, Tampere, Finland.
  • Paulo P; Department of Urology, Tampere University Hospital and School of Medicine, University of Tampere, Tampere, Finland.
  • Jerónimo C; The Institute of Cancer Research, London, UK.
  • Henrique R; Department of Biological Science, University of East Anglia, Norwich, UK.
  • Krause H; The Institute of Cancer Research, London, UK.
  • Wach S; The Institute of Cancer Research, London, UK.
  • Lieb V; The Institute of Cancer Research, London, UK.
  • Rau TT; The Institute of Cancer Research, London, UK.
  • Vogel W; Royal Marsden National Health Service Foundation Trust, London and Sutton, UK.
  • Kuefer R; The Institute of Cancer Research, London, UK.
  • Hofer MD; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
  • Perner S; Abel Salazar Biomedical Sciences Institute, Porto University, Porto, Portugal.
  • Rubin MA; Abel Salazar Biomedical Sciences Institute, Porto University, Porto, Portugal.
  • Agarwal AM; Department of Pathology, Portuguese Oncology Institute, Porto, Portugal.
  • Easton DF; Abel Salazar Biomedical Sciences Institute, Porto University, Porto, Portugal.
  • Al Olama AA; Department of Pathology, Portuguese Oncology Institute, Porto, Portugal.
  • Benlloch S; Department of Urology, University Hospital Charité, Berlin, Germany.
  • Hoegel J; Department of Urology, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.
  • Stanford JL; Institute of Pathology, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.
  • Maier C; Institute of Pathology, University Bern, Bern Switzerland.
Hum Mol Genet ; 25(24): 5490-5499, 2016 12 15.
Article em En | MEDLINE | ID: mdl-27798103
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Serina Endopeptidases / Proteínas de Fusão Oncogênica Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Hum Mol Genet Assunto da revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Serina Endopeptidases / Proteínas de Fusão Oncogênica Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Hum Mol Genet Assunto da revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido